Literature DB >> 19652887

High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1.

Ben Lv1, Haichao Wang, Yiting Tang, Zhang Fan, Xianzhong Xiao, Fangping Chen.   

Abstract

High-mobility group box 1 protein (HMGB1), an abundant nuclear protein, was recently established as a proinflammatory mediator of experimental sepsis. Although extracellular HMGB1 has been found in atherosclerotic plaques, its potential role in the pathogenesis of atherothrombosis remains elusive. In the present study, we determined whether HMGB1 induces tissue factor (TF) expression in vascular endothelial cells (ECs) and macrophages. Our data showed that HMGB1 stimulated ECs to express TF (but not TF pathway inhibitor) mRNA and protein in a concentration- and time-dependent manner. Blockade of cell surface receptors (including TLR4, TLR2, and RAGE) with specific neutralising antibodies partially reduced HMGB1-induced TF expression. Moreover, HMGB1 increased expression of Egr-1 and nuclear translocation of NF-kappaB (c-Rel/p65) in ECs. Taken together, our data suggest that HMGB1 induces TF expression in vascular endothelial cells via cell surface receptors (TLR4, TLR2, and RAGE), and through activation of transcription factors (NF-kappaB and Egr-1).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652887      PMCID: PMC2860734          DOI: 10.1160/TH08-11-0759

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  35 in total

1.  Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells.

Authors:  H Kawano; H Tsuji; H Nishimura; S Kimura; S Yano; N Ukimura; Y Kunieda; M Yoshizumi; T Sugano; K Nakagawa; H Masuda; S Sawada; M Nakagawa
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein.

Authors:  Annalisa Porto; Roberta Palumbo; Maurizio Pieroni; Gianfranco Aprigliano; Roberto Chiesa; Francesca Sanvito; Attilio Maseri; Marco E Bianchi
Journal:  FASEB J       Date:  2006-10-23       Impact factor: 5.191

3.  Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.

Authors:  B Du; C Fu; K C Kent; H Bush; A H Schulick; K Kreiger; T Collins; T A McCaffrey
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

4.  High-mobility group box 1 protein promotes development of microvascular thrombosis in rats.

Authors:  T Ito; K Kawahara; T Nakamura; S Yamada; T Nakamura; K Abeyama; T Hashiguchi; I Maruyama
Journal:  J Thromb Haemost       Date:  2007-01       Impact factor: 5.824

5.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

Authors:  Beatriz Rendon-Mitchell; Mahendar Ochani; Jianhua Li; Jialian Han; Hong Wang; Huan Yang; Seenu Susarla; Christopher Czura; Robert A Mitchell; Guoqian Chen; Andrew E Sama; Kevin J Tracey; Haichao Wang
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice.

Authors:  Gernot Schabbauer; Michael Tencati; Brian Pedersen; Rafal Pawlinski; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

7.  Crosstalk between coagulation and inflammation during Dengue virus infection.

Authors:  Alejandra Huerta-Zepeda; Carlos Cabello-Gutiérrez; Jorge Cime-Castillo; Verónica Monroy-Martínez; Maria Eugenia Manjarrez-Zavala; Margarita Gutiérrez-Rodríguez; Raúl Izaguirre; Blanca H Ruiz-Ordaz
Journal:  Thromb Haemost       Date:  2008-05       Impact factor: 5.249

Review 8.  Extracellular role of HMGB1 in inflammation and sepsis.

Authors:  H Wang; H Yang; K J Tracey
Journal:  J Intern Med       Date:  2004-03       Impact factor: 8.989

9.  Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity.

Authors:  Markus Puhlmann; David M Weinreich; Jeffrey M Farma; Nancy M Carroll; Ewa M Turner; H Richard Alexander
Journal:  J Transl Med       Date:  2005-09-30       Impact factor: 5.531

10.  Role of HMGB1 in apoptosis-mediated sepsis lethality.

Authors:  Shixin Qin; Haichao Wang; Renqi Yuan; Hui Li; Mahendar Ochani; Kanta Ochani; Mauricio Rosas-Ballina; Chris J Czura; Jared M Huston; Ed Miller; Xinchun Lin; Barbara Sherry; Anjali Kumar; Greg Larosa; Walter Newman; Kevin J Tracey; Huan Yang
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  29 in total

1.  HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways.

Authors:  Wenchang Huang; Yiyun Liu; Lei Li; Ruyuan Zhang; Wei Liu; Jun Wu; Enqiang Mao; Yaoqing Tang
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats.

Authors:  Haichao Wang; Wei Li; Shu Zhu; Jianhua Li; Jason D'Amore; Mary F Ward; Huan Yang; Rongqian Wu; Willi Jahnen-Dechent; Kevin J Tracey; Ping Wang; Andrew E Sama
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-02       Impact factor: 6.200

3.  Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake.

Authors:  Yusong Zhang; Wei Li; Shu Zhu; Arvin Jundoria; Jianhua Li; Huan Yang; Saijun Fan; Ping Wang; Kevin J Tracey; Andrew E Sama; Haichao Wang
Journal:  Biochem Pharmacol       Date:  2012-09-26       Impact factor: 5.858

4.  The role of type 1 interferons in coagulation induced by gram-negative bacteria.

Authors:  Xinyu Yang; Xiaoye Cheng; Yiting Tang; Xianhui Qiu; Zhongtai Wang; Guang Fu; Jianfeng Wu; Haixia Kang; Jing Wang; Haichao Wang; Fangping Chen; Xianzhong Xiao; Timothy R Billiar; Ben Lu
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

Review 5.  Anti-inflammatory role of fetuin-A in injury and infection.

Authors:  H Wang; A E Sama
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

6.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

7.  Abnormal expression of Toll-like receptor 4 is associated with susceptibility to ethanol-induced gastric mucosal injury in mice.

Authors:  Hui-hui Ye; Rong Hua; Le Yu; Ke-jian Wu; Su-juan Fei; Xia Qin; Ying Song; Jun-li Cao; Yong-mei Zhang
Journal:  Dig Dis Sci       Date:  2013-06-07       Impact factor: 3.199

8.  Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.

Authors:  Christian Giordano; Kamalika Mojumdar; Feng Liang; Christian Lemaire; Tong Li; John Richardson; Maziar Divangahi; Salman Qureshi; Basil J Petrof
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

Review 9.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.